Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

Complex Mixtures > Biological Products > Vaccines > Vaccines, Combined > BNT162b5
... > Complex Mixtures > Biological Products > Vaccines > Viral Vaccines > COVID-19 Vaccines > BNT162b5
... > Complex Mixtures > Biological Products > Vaccines > Vaccines, Subunit > Vaccines, Acellular > mRNA Vaccines > BNT162b5
... > Biological Factors > Antigens > Vaccines, Synthetic > Nucleic Acid-Based Vaccines > mRNA Vaccines > BNT162b5
... > Complex Mixtures > Biological Products > Vaccines > Vaccines, Synthetic > Nucleic Acid-Based Vaccines > mRNA Vaccines > BNT162b5
... > Amino Acids, Peptides, and Proteins > Proteins > Recombinant Proteins > Vaccines, Synthetic > Nucleic Acid-Based Vaccines > mRNA Vaccines > BNT162b5

Preferred term

BNT162b5  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • COVID 19 Vaccine Pfizer BioNTech, Bivalent
  • COVID-19 Vaccine Pfizer-BioNTech, Bivalent

Scope note

  • A combined mRNA vaccine, developed by Pfizer and BioNTech against SARS-CoV-2 with a mixture of the original strain of SARS-CoV-2 and BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2.

History note

  • 2024

In other languages

  • BNT162b5

    Finnish

  • BNT162b5-koronarokote
  • BNT162b5-rokote
  • BNT162b5-rokote COVID-19:ää vastaan
  • BNT162b5

    Swedish

URI

http://www.yso.fi/onto/mesh/D000096106

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/26/23, last modified 5/22/23